v3.26.1
Condensed Consolidated Statements of Income - USD ($)
shares in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenues $ 3,333,900,000 $ 2,964,700,000 $ 6,320,800,000 $ 5,734,900,000
Costs and expenses:        
Cost of sales 489,200,000 407,500,000 882,000,000.0 770,500,000
Research and development expenses 993,800,000 978,400,000 1,955,400,000 1,958,100,000
Acquired in-process research and development expenses 21,400,000 2,200,000 21,900,000 22,000,000.0
Selling, general and administrative expenses 582,200,000 424,600,000 1,075,900,000 821,000,000.0
Intangible asset impairment charge 0 0 0 379,000,000.0
Change in fair value of contingent consideration 400,000 900,000 600,000 3,100,000
Total costs and expenses 2,087,000,000 1,813,600,000 3,935,800,000 3,953,700,000
Income from operations 1,246,900,000 1,151,100,000 2,385,000,000 1,781,200,000
Interest income, net 120,600,000 118,700,000 235,400,000 236,600,000
Other income (expense), net 24,300,000 13,200,000 24,300,000 (4,400,000)
Income before Provision for income taxes 1,391,800,000 1,283,000,000 2,644,700,000 2,013,400,000
Provision for income taxes 292,000,000.0 250,100,000 513,500,000 334,200,000
Net income $ 1,099,800,000 $ 1,032,900,000 $ 2,131,200,000 $ 1,679,200,000
Net income per common share:        
Basic (in dollars per share) $ 4.34 $ 4.02 $ 8.39 $ 6.54
Diluted (in dollars per share) $ 4.31 $ 3.99 $ 8.33 $ 6.48
Shares used in per share calculations:        
Basic (in shares) 253.7 256.7 253.9 256.8
Diluted (in shares) 255.2 258.9 255.7 259.2
Product revenues, net        
Total revenues $ 3,333,900,000 $ 2,944,000,000 $ 6,320,800,000 $ 5,704,200,000
Other revenues        
Total revenues $ 0 $ 20,700,000 $ 0 $ 30,700,000